首页 > 最新文献

Journal of Mid-life Health最新文献

英文 中文
Mesh Infection in Sacrocolpopexy: A Novel Approach to Management. 骶尾部结肠切除术中的网片感染:一种新的处理方法。
IF 1.2 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2024-04-01 Epub Date: 2024-07-05 DOI: 10.4103/jmh.jmh_238_23
Reeti Mehra, Shubhi Bandlish

Surgical mesh has been in use for urogynecological surgeries for a long, but they come with their own side effect profile and maybe life-altering consequences. We discuss a novel method of management of mesh erosion and infection in a patient with mesh sacrocolpopexy.

手术网片用于泌尿妇科手术由来已久,但它们也有自己的副作用,可能会造成改变生命的后果。我们将讨论一种处理网片骶骨整形术患者网片侵蚀和感染的新方法。
{"title":"Mesh Infection in Sacrocolpopexy: A Novel Approach to Management.","authors":"Reeti Mehra, Shubhi Bandlish","doi":"10.4103/jmh.jmh_238_23","DOIUrl":"10.4103/jmh.jmh_238_23","url":null,"abstract":"<p><p>Surgical mesh has been in use for urogynecological surgeries for a long, but they come with their own side effect profile and maybe life-altering consequences. We discuss a novel method of management of mesh erosion and infection in a patient with mesh sacrocolpopexy.</p>","PeriodicalId":37717,"journal":{"name":"Journal of Mid-life Health","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11321513/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141983511","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Robotic-assisted Versus Conventional Laparoscopic Hysterectomy for Benign Gynecological Conditions: A Systematic Review and Meta-analysis. 针对良性妇科疾病的机器人辅助与传统腹腔镜子宫切除术:系统回顾与元分析》。
IF 1.2 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2024-04-01 Epub Date: 2024-07-05 DOI: 10.4103/jmh.jmh_235_23
Anupama Bahadur, Rabia Zaman, Rajlaxmi Mundhra, Kalaivani Mani

Background: Minimally invasive gynecologic surgery is safe and feasible procedure for benign gynaecological conditions with less morbidity.

Objective: To determine the best approach in benign gynecology and establish superiority of robotic over conventional laparoscopic hysterectomy in terms of safety and effectiveness.

Methods: Search strategy: Electronic databases: MEDLINE, Embase, CENTRAL (the Registry of Controlled Clinical Studies of the Cochrane Collaboration), Google scholar, Pubmed and Scopus were searched from 2010-2022. Selection criteria: All randomized controlled trials and quasi-randomised trials which compared robotic versus conventional laparoscopic hysterectomy were included to conduct this systematic review and meta-analysis to investigate compared to traditional approaches.

Results: Only five RCTs (326 patients in total) comparing robotic and conventional laparoscopic hysterectomy were included after a comprehensive literature search. Results of our analysis showed no clear benefit in any of the two techniques in operating time, estimated blood loss, length of hospital stay and overall complications.

Conclusion: This systematic review suggests no statistical difference in surgical and patient outcomes between robotic and conventional laparoscopic hysterectomy relating to OT, EBL, LOHS, overall complications, and survival.

背景:微创妇科手术是一种安全可行的良性妇科疾病手术,发病率较低:微创妇科手术是治疗妇科良性疾病的安全可行的方法,且发病率较低:确定良性妇科手术的最佳方法,并确定机器人子宫切除术在安全性和有效性方面优于传统腹腔镜手术:搜索策略:电子数据库:检索时间:2010-2022 年,电子数据库:MEDLINE、Embase、CENTRAL(Cochrane 协作组织对照临床研究注册中心)、Google scholar、Pubmed 和 Scopus。选择标准:纳入所有比较机器人与传统腹腔镜子宫切除术的随机对照试验和准随机试验,进行系统综述和荟萃分析,研究与传统方法的比较:结果:经过全面的文献检索,仅纳入了五项比较机器人与传统腹腔镜子宫切除术的 RCT(共 326 名患者)。我们的分析结果显示,两种技术在手术时间、估计失血量、住院时间和总体并发症方面均无明显优势:本系统综述表明,机器人与传统腹腔镜子宫切除术在手术时间、EBL、LOHS、总体并发症和存活率方面的手术和患者预后没有统计学差异。
{"title":"Robotic-assisted Versus Conventional Laparoscopic Hysterectomy for Benign Gynecological Conditions: A Systematic Review and Meta-analysis.","authors":"Anupama Bahadur, Rabia Zaman, Rajlaxmi Mundhra, Kalaivani Mani","doi":"10.4103/jmh.jmh_235_23","DOIUrl":"10.4103/jmh.jmh_235_23","url":null,"abstract":"<p><strong>Background: </strong>Minimally invasive gynecologic surgery is safe and feasible procedure for benign gynaecological conditions with less morbidity.</p><p><strong>Objective: </strong>To determine the best approach in benign gynecology and establish superiority of robotic over conventional laparoscopic hysterectomy in terms of safety and effectiveness.</p><p><strong>Methods: </strong>Search strategy: Electronic databases: MEDLINE, Embase, CENTRAL (the Registry of Controlled Clinical Studies of the Cochrane Collaboration), Google scholar, Pubmed and Scopus were searched from 2010-2022. Selection criteria: All randomized controlled trials and quasi-randomised trials which compared robotic versus conventional laparoscopic hysterectomy were included to conduct this systematic review and meta-analysis to investigate compared to traditional approaches.</p><p><strong>Results: </strong>Only five RCTs (326 patients in total) comparing robotic and conventional laparoscopic hysterectomy were included after a comprehensive literature search. Results of our analysis showed no clear benefit in any of the two techniques in operating time, estimated blood loss, length of hospital stay and overall complications.</p><p><strong>Conclusion: </strong>This systematic review suggests no statistical difference in surgical and patient outcomes between robotic and conventional laparoscopic hysterectomy relating to OT, EBL, LOHS, overall complications, and survival.</p>","PeriodicalId":37717,"journal":{"name":"Journal of Mid-life Health","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11321512/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141983527","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Utility of the United Kingdom National Health Services Breast Screening Program Diagnostic Protocol in Fine-needle Aspiration Cytology with Cell Block Preparation in Cases of Palpable Breast Lumps: A Reliable, Fast, and Accurate Diagnostic Method for the Assessment of Breast Lumps with Histopathologic Correlation. 英国国家卫生服务乳腺筛查计划诊断规程在可触及乳腺肿块病例的细针抽吸细胞学与细胞块制备中的实用性:一种可靠、快速、准确的诊断方法,用于评估与组织病理学相关的乳腺肿块。
IF 1.2 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2024-04-01 Epub Date: 2024-07-05 DOI: 10.4103/jmh.jmh_187_23
Pratik Bharatbhai Desai, Killol Nathubhai Desai, Nirav Sureshbhai Panchal

Introduction: A palpable breast lump is a common diagnostic problem for clinicians and surgeons. Fine-needle aspiration cytology (FNAC) has many advantages such as less cost, less sample processing time, less pain, less chance of hematoma, and less discomfort. FNAC with cell block preparation further increased both sensitivity and specificity by nearly 100%. With the cell block preparation, we can also use newer tests like estrogen receptor-progesterone receptor-human epidermal growth factor receptor 2.

Aims: The aim of this study was to derive conclusions about the correlation, including sensitivity, specificity, positive and negative predictive values (NPVs), and the diagnostic accuracy of FNAC, with or without cell blocks, compared to the final histopathology in cases of palpable breast masses.

Materials and methods: A cross-sectional prospective study was conducted after getting approval from the Human Ethics Research Committee from January 2018 to December 2019, which included 65 patients. Patients diagnosed clinically for breast lumps who underwent diagnostic FNAC with cell block, followed by a histopathological examination at our hospital, were included in the study.

Results: FNAC without cell block sensitivity, specificity, positive predictive value (PPV), NPV, efficiency rate, and diagnostic accuracy are 91.3%, 100%, 100%, 90.1%, 86.2%, and 96.5%, respectively. FNAC with cell block sensitivity, specificity, PPV, NPV, efficiency rate, and diagnostic accuracy are all 100%. All of our results beat the standard estimate.

Conclusions: Fine-needle aspiration cytology is a patient-friendly, easy, reliable, repeatable, and simple diagnostic test. Whenever it is combined with cell block preparation, improves the accuracy of FNAC diagnosis which is more accurate and comparable to golden-standard biopsy with histopathology examination.

导言:可触及的乳房肿块是临床医生和外科医生常见的诊断问题。细针穿刺细胞学检查(FNAC)具有成本低、样本处理时间短、痛苦小、血肿机会少、不适感轻等诸多优点。采用细胞块制备的 FNAC 进一步提高了灵敏度和特异性,几乎达到 100%。目的:本研究的目的是对可触及的乳腺肿块病例进行相关性分析,包括敏感性、特异性、阳性和阴性预测值(NPV),以及有无细胞块的 FNAC 与最终组织病理学的诊断准确性进行比较:2018年1月至2019年12月,经人类伦理研究委员会批准,开展了一项横断面前瞻性研究,共纳入65名患者。经临床诊断为乳腺肿块的患者在我院接受了带细胞阻滞的 FNAC 诊断,随后进行了组织病理学检查:无细胞阻滞的 FNAC 敏感性、特异性、阳性预测值 (PPV)、NPV、有效率和诊断准确率分别为 91.3%、100%、100%、90.1%、86.2% 和 96.5%。带细胞块的 FNAC 敏感性、特异性、PPV、NPV、有效率和诊断准确率均为 100%。我们的所有结果都优于标准估计值:结论:细针穿刺细胞学检查是一种方便患者、简易、可靠、可重复和简单的诊断检查。只要结合细胞块制备,就能提高 FNAC 诊断的准确性,其准确性可媲美黄金标准活检和组织病理学检查。
{"title":"Utility of the United Kingdom National Health Services Breast Screening Program Diagnostic Protocol in Fine-needle Aspiration Cytology with Cell Block Preparation in Cases of Palpable Breast Lumps: A Reliable, Fast, and Accurate Diagnostic Method for the Assessment of Breast Lumps with Histopathologic Correlation.","authors":"Pratik Bharatbhai Desai, Killol Nathubhai Desai, Nirav Sureshbhai Panchal","doi":"10.4103/jmh.jmh_187_23","DOIUrl":"10.4103/jmh.jmh_187_23","url":null,"abstract":"<p><strong>Introduction: </strong>A palpable breast lump is a common diagnostic problem for clinicians and surgeons. Fine-needle aspiration cytology (FNAC) has many advantages such as less cost, less sample processing time, less pain, less chance of hematoma, and less discomfort. FNAC with cell block preparation further increased both sensitivity and specificity by nearly 100%. With the cell block preparation, we can also use newer tests like estrogen receptor-progesterone receptor-human epidermal growth factor receptor 2.</p><p><strong>Aims: </strong>The aim of this study was to derive conclusions about the correlation, including sensitivity, specificity, positive and negative predictive values (NPVs), and the diagnostic accuracy of FNAC, with or without cell blocks, compared to the final histopathology in cases of palpable breast masses.</p><p><strong>Materials and methods: </strong>A cross-sectional prospective study was conducted after getting approval from the Human Ethics Research Committee from January 2018 to December 2019, which included 65 patients. Patients diagnosed clinically for breast lumps who underwent diagnostic FNAC with cell block, followed by a histopathological examination at our hospital, were included in the study.</p><p><strong>Results: </strong>FNAC without cell block sensitivity, specificity, positive predictive value (PPV), NPV, efficiency rate, and diagnostic accuracy are 91.3%, 100%, 100%, 90.1%, 86.2%, and 96.5%, respectively. FNAC with cell block sensitivity, specificity, PPV, NPV, efficiency rate, and diagnostic accuracy are all 100%. All of our results beat the standard estimate.</p><p><strong>Conclusions: </strong>Fine-needle aspiration cytology is a patient-friendly, easy, reliable, repeatable, and simple diagnostic test. Whenever it is combined with cell block preparation, improves the accuracy of FNAC diagnosis which is more accurate and comparable to golden-standard biopsy with histopathology examination.</p>","PeriodicalId":37717,"journal":{"name":"Journal of Mid-life Health","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11321524/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141983530","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Diagnosis of Sheehan's Syndrome: Better Late Than Never. 希恩综合症的诊断:迟来总比没有好。
IF 1.2 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2024-04-01 Epub Date: 2024-07-05 DOI: 10.4103/jmh.jmh_66_24
Aakash Pandey, Sagar Mallappa Sindagi, Harshita Singh, Paridhi Singhal, Priya Bansal, Motilal Negi

A middle-aged woman presented with history of fatigue, low mood, swelling of limbs, and facial puffiness. On detailed history taking, she also complained of salt craving, secondary amenorrhea, and loss of libido for almost a decade. Investigations revealed pan-hypopituitarism. She was started on appropriate hormonal therapy which saw a rapid resolution of symptoms within 2 weeks. Sheehan's syndrome may have an acute presentation or chronic. The symptoms may be subtle like fatigue or overt like hypotension and syncope. A high degree of suspicion of Sheehan's syndrome is essential for its timely management, and goes a long way in preserving the quality of life.

一名中年女性因疲劳、情绪低落、四肢浮肿和面部浮肿前来就诊。在详细询问病史后,她还抱怨自己近十年来嗜盐、继发性闭经和性欲减退。检查发现她患有泛垂体功能减退症。她开始接受适当的激素治疗,症状在两周内迅速缓解。希恩综合征可能是急性发作,也可能是慢性发作。症状可能是微弱的,如疲劳,也可能是明显的,如低血压和晕厥。高度怀疑 Sheehan's 综合征是及时治疗的关键,对保护患者的生活质量大有裨益。
{"title":"A Diagnosis of Sheehan's Syndrome: Better Late Than Never.","authors":"Aakash Pandey, Sagar Mallappa Sindagi, Harshita Singh, Paridhi Singhal, Priya Bansal, Motilal Negi","doi":"10.4103/jmh.jmh_66_24","DOIUrl":"10.4103/jmh.jmh_66_24","url":null,"abstract":"<p><p>A middle-aged woman presented with history of fatigue, low mood, swelling of limbs, and facial puffiness. On detailed history taking, she also complained of salt craving, secondary amenorrhea, and loss of libido for almost a decade. Investigations revealed pan-hypopituitarism. She was started on appropriate hormonal therapy which saw a rapid resolution of symptoms within 2 weeks. Sheehan's syndrome may have an acute presentation or chronic. The symptoms may be subtle like fatigue or overt like hypotension and syncope. A high degree of suspicion of Sheehan's syndrome is essential for its timely management, and goes a long way in preserving the quality of life.</p>","PeriodicalId":37717,"journal":{"name":"Journal of Mid-life Health","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11321522/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141983503","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Carcinoma Endometrium Coexisting in Huge Procidentia. 子宫内膜癌并存于巨大的前列腺。
IF 1.2 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2024-04-01 Epub Date: 2024-07-05 DOI: 10.4103/jmh.jmh_205_23
Rajlaxmi Mundhra, Anupama Bahadur, Rashmi Rajput, Arvind Kumar

Surgery remains the gold standard treatment for endometrial cancer. Vaginal approach is suitable for candidates with low risk for lymph node metastasis or in elderly females with extensive comorbidities, especially when surgery is done for palliative purpose only. We herein describe a case of cancer endometrium in huge procidentia, managed by vaginal hysterectomy followed by hormonal therapy.

手术仍是治疗子宫内膜癌的金标准。阴道手术适用于淋巴结转移风险较低的患者或合并症较多的老年女性,尤其是手术仅用于姑息治疗时。我们在此描述了一例巨大原位子宫内膜癌患者,该患者经阴道切除子宫后接受了激素治疗。
{"title":"Carcinoma Endometrium Coexisting in Huge Procidentia.","authors":"Rajlaxmi Mundhra, Anupama Bahadur, Rashmi Rajput, Arvind Kumar","doi":"10.4103/jmh.jmh_205_23","DOIUrl":"10.4103/jmh.jmh_205_23","url":null,"abstract":"<p><p>Surgery remains the gold standard treatment for endometrial cancer. Vaginal approach is suitable for candidates with low risk for lymph node metastasis or in elderly females with extensive comorbidities, especially when surgery is done for palliative purpose only. We herein describe a case of cancer endometrium in huge procidentia, managed by vaginal hysterectomy followed by hormonal therapy.</p>","PeriodicalId":37717,"journal":{"name":"Journal of Mid-life Health","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11321510/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141983506","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nontraditional Lipid Parameters as a Predictor of Cardiovascular Disease Risk in Nepalese Women. 作为尼泊尔妇女心血管疾病风险预测指标的非传统血脂参数。
IF 1.2 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2024-04-01 Epub Date: 2024-07-05 DOI: 10.4103/jmh.jmh_179_23
Jasper Adhikaree, Ruyusha Shrestha, Prabina Bomjan, Shreya Pokharel, Ashmita Shrestha, Anusha Siwakoti, Rashila Acharya, Roy Rillera Marzo, Swosti Acharya, Ritesh Pokhrel, Prachand Man Singh Rajbhandari

Background: The use of nontraditional lipid parameters for assessing clinical conditions is emerging; however, no study has identified thresholds for those parameters for the identification of cardiovascular disease (CVD) risk. The present study aimed to establish the thresholds of nontraditional lipid parameters and test its ability to identify CVD risk factors.

Methodology: A cross-sectional study in women (n = 369, age: 46 ± 13 years, body mass index (BMI): 26.31 ± 2.54 kg/m2) was conducted. Blood samples were collected and high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol, total cholesterol (TC), and triglycerides (TGs) were estimated. Subsequently, nontraditional lipid parameters were calculated, namely non-HDL-C, Castelli's Risk Index II (CRI-II), CRI-I, lipoprotein combined index (LCI), atherogenic index (AI), and AI of plasma (AIP).

Results: Based on TC (≥200 mg/dL), the derived thresholds for non-HDL-C, CRI-II, CRI-I, LCI, AI, and AIP were 139 mg/dL, 2.29, 3.689, 58,066, 2.687, and 0.487, respectively. Similarly, based on the threshold of TG (≥150 mg/dL), the derived thresholds for non-HDL-C, CRI-II, CRI-I, LCI, AI, and AIP were 127 mg/dL, 2.3, 3.959, 58,251, 2.959, and 0.467, respectively. Out of considered five risk factors, non-HDL-C, CRI-II, CRI-I, LCI, and AI thresholds were capable in identifying four risk factors (physical activity, blood pressure, BMI, and age) and AIP was able to associate with two risk factors at most (blood pressure and BMI).

Conclusion: The derived thresholds of nontraditional lipid parameters were capable of differentiating between CVD risk and nonrisk groups suggesting the possible use of these thresholds for studying CVD risk.

背景:使用非传统血脂参数评估临床状况的做法正在兴起;然而,还没有研究确定这些参数用于识别心血管疾病(CVD)风险的阈值。本研究旨在确定非传统血脂参数的阈值,并测试其识别心血管疾病风险因素的能力:对女性(n = 369,年龄:46 ± 13 岁,体重指数(BMI):26.31 ± 2.54 kg/m2)进行横断面研究。研究人员采集了血液样本,并估算了高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇、总胆固醇(TC)和甘油三酯(TGs)。随后计算了非传统血脂参数,即非高密度脂蛋白胆固醇、卡斯泰利风险指数 II(CRI-II)、CRI-I、脂蛋白综合指数(LCI)、致动脉粥样硬化指数(AI)和血浆AI(AIP):根据血清总胆固醇(≥200 毫克/分升),非高密度脂蛋白胆固醇、CRI-II、CRI-I、LCI、AI 和 AIP 的阈值分别为 139 毫克/分升、2.29、3.689、58,066、2.687 和 0.487。同样,根据总胆固醇的阈值(≥150 毫克/分升),非高密度脂蛋白胆固醇、CRI-II、CRI-I、LCI、AI 和 AIP 的阈值分别为 127 毫克/分升、2.3、3.959、58 251、2.959 和 0.467。在考虑的五个风险因素中,非高密度脂蛋白胆固醇、CRI-II、CRI-I、LCI 和 AI 临界值能够识别四个风险因素(体力活动、血压、体重指数和年龄),而 AIP 最多能够与两个风险因素(血压和体重指数)相关联:结论:得出的非传统血脂参数阈值能够区分心血管疾病风险组和非风险组,这表明这些阈值可用于研究心血管疾病风险。
{"title":"Nontraditional Lipid Parameters as a Predictor of Cardiovascular Disease Risk in Nepalese Women.","authors":"Jasper Adhikaree, Ruyusha Shrestha, Prabina Bomjan, Shreya Pokharel, Ashmita Shrestha, Anusha Siwakoti, Rashila Acharya, Roy Rillera Marzo, Swosti Acharya, Ritesh Pokhrel, Prachand Man Singh Rajbhandari","doi":"10.4103/jmh.jmh_179_23","DOIUrl":"10.4103/jmh.jmh_179_23","url":null,"abstract":"<p><strong>Background: </strong>The use of nontraditional lipid parameters for assessing clinical conditions is emerging; however, no study has identified thresholds for those parameters for the identification of cardiovascular disease (CVD) risk. The present study aimed to establish the thresholds of nontraditional lipid parameters and test its ability to identify CVD risk factors.</p><p><strong>Methodology: </strong>A cross-sectional study in women (<i>n</i> = 369, age: 46 ± 13 years, body mass index (BMI): 26.31 ± 2.54 kg/m<sup>2</sup>) was conducted. Blood samples were collected and high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol, total cholesterol (TC), and triglycerides (TGs) were estimated. Subsequently, nontraditional lipid parameters were calculated, namely non-HDL-C, Castelli's Risk Index II (CRI-II), CRI-I, lipoprotein combined index (LCI), atherogenic index (AI), and AI of plasma (AIP).</p><p><strong>Results: </strong>Based on TC (≥200 mg/dL), the derived thresholds for non-HDL-C, CRI-II, CRI-I, LCI, AI, and AIP were 139 mg/dL, 2.29, 3.689, 58,066, 2.687, and 0.487, respectively. Similarly, based on the threshold of TG (≥150 mg/dL), the derived thresholds for non-HDL-C, CRI-II, CRI-I, LCI, AI, and AIP were 127 mg/dL, 2.3, 3.959, 58,251, 2.959, and 0.467, respectively. Out of considered five risk factors, non-HDL-C, CRI-II, CRI-I, LCI, and AI thresholds were capable in identifying four risk factors (physical activity, blood pressure, BMI, and age) and AIP was able to associate with two risk factors at most (blood pressure and BMI).</p><p><strong>Conclusion: </strong>The derived thresholds of nontraditional lipid parameters were capable of differentiating between CVD risk and nonrisk groups suggesting the possible use of these thresholds for studying CVD risk.</p>","PeriodicalId":37717,"journal":{"name":"Journal of Mid-life Health","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11321523/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141983512","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Frozen in Time: Intraoperative Diagnosis and Management of Malignant Transformation in Mature Cystic Teratoma. 时间定格:成熟囊性畸胎瘤恶变的术中诊断和处理。
IF 1.2 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2024-04-01 Epub Date: 2024-07-05 DOI: 10.4103/jmh.jmh_253_23
Arun Sudhakar Sanap, Medha D Davile, Anusha A Kamath, Shuchita R Mundle

Malignant transformation (MCT) of ovary is rare complications affecting elderly, squamous cell carcinoma being the most common. The prognosis worsens with extraovarian spread. We present two cases of MCT-derived SCC. Patients exhibited abdominal lump, pain, bowel symptoms, sometimes with weight loss; imaging revealed MCT. Age (51-60), postmenopausal status, large size (>20 cm), bilaterality, and complex ovarian lesions raised suspicion of malignancy. Elevated tumor markers (e.g., cancer antigen-125 and lactate dehydrogenase) were noted in one case. Intraoperative frozen section confirmed malignancy, guiding staging laparotomy. One case was advanced stage on histopathology. Intraoperative frozen section aids optimal staging.

卵巢恶性转化(MCT)是影响老年人的罕见并发症,其中最常见的是鳞状细胞癌。其预后会随着卵巢外扩散而恶化。我们报告了两例 MCT 衍生的 SCC。患者表现为腹部肿块、疼痛、肠道症状,有时伴有体重减轻;造影显示为 MCT。年龄(51-60 岁)、绝经后状态、体积大(>20 厘米)、双侧、卵巢病变复杂,这些都引起了对恶性肿瘤的怀疑。其中一个病例的肿瘤标志物(如癌抗原-125 和乳酸脱氢酶)升高。术中冰冻切片证实了恶性肿瘤,为分期开腹手术提供了指导。有一例病例经组织病理学检查为晚期。术中冰冻切片有助于最佳分期。
{"title":"Frozen in Time: Intraoperative Diagnosis and Management of Malignant Transformation in Mature Cystic Teratoma.","authors":"Arun Sudhakar Sanap, Medha D Davile, Anusha A Kamath, Shuchita R Mundle","doi":"10.4103/jmh.jmh_253_23","DOIUrl":"10.4103/jmh.jmh_253_23","url":null,"abstract":"<p><p>Malignant transformation (MCT) of ovary is rare complications affecting elderly, squamous cell carcinoma being the most common. The prognosis worsens with extraovarian spread. We present two cases of MCT-derived SCC. Patients exhibited abdominal lump, pain, bowel symptoms, sometimes with weight loss; imaging revealed MCT. Age (51-60), postmenopausal status, large size (>20 cm), bilaterality, and complex ovarian lesions raised suspicion of malignancy. Elevated tumor markers (e.g., cancer antigen-125 and lactate dehydrogenase) were noted in one case. Intraoperative frozen section confirmed malignancy, guiding staging laparotomy. One case was advanced stage on histopathology. Intraoperative frozen section aids optimal staging.</p>","PeriodicalId":37717,"journal":{"name":"Journal of Mid-life Health","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11321514/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141983510","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Revolutionizing Menopause Management: Harnessing the Potential of Artificial Intelligence. 革新更年期管理:利用人工智能的潜力。
IF 1.2 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2024-04-01 Epub Date: 2024-07-05 DOI: 10.4103/jmh.jmh_104_24
Ruchika Garg, Atul Munshi
{"title":"Revolutionizing Menopause Management: Harnessing the Potential of Artificial Intelligence.","authors":"Ruchika Garg, Atul Munshi","doi":"10.4103/jmh.jmh_104_24","DOIUrl":"10.4103/jmh.jmh_104_24","url":null,"abstract":"","PeriodicalId":37717,"journal":{"name":"Journal of Mid-life Health","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11321517/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141983526","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring the Efficacy and Safety of Black Cohosh (Cimicifuga racemosa) in Menopausal Symptom Management. 探索黑升麻(Cimicifuga racemosa)治疗更年期症状的有效性和安全性。
IF 1.1 Q3 Social Sciences Pub Date : 2024-01-01 Epub Date: 2024-04-04 DOI: 10.4103/jmh.jmh_242_23
Kritiksha Hedaoo, Ankit K Badge, Yugeshwari R Tiwade, Nandkishor J Bankar, Vaishnavi H Mishra

Black cohosh (Cimicifuga racemosa) is a perennial plant used to treat menopause. This plant is known to have a serotonergic rather than estrogenic impact. It has been recommended to treat vasomotor symptoms associated with breast cancer patients. It also relieves symptoms such as night sweats and hot flashes, commonly called vasorelaxation. The variability in the study's results, doses, and assessment methods requires more rigorous research to establish its efficacy and safety. Standardized trials are needed to provide more precise information on the benefits and limitations of menopause treatment, informing women seeking alternatives to hormone therapy. Black cohosh has shown the potential to reduce the frequency and intensity of vasomotor symptoms in breast cancer patients undergoing tamoxifen treatment. In addition to its effectiveness in alleviating night sweats and hot flashes, the vasorelaxation properties contribute to its overall positive impact on menopausal symptoms. Due to discrepancies, varying dosages, and assessment techniques, further comprehensive studies are essential to determine the optimal dosage, long-term safety, and overall efficacy. Only through standardized trials can women make informed decisions about black cohosh as a viable alternative to hormone therapy during menopause.

黑升麻(Cimicifuga racemosa)是一种用于治疗更年期的多年生植物。众所周知,这种植物具有血清素而非雌激素的影响。它被推荐用于治疗乳腺癌患者的血管运动症状。它还能缓解盗汗和潮热等症状,通常称为血管舒张。由于研究结果、剂量和评估方法存在差异,因此需要进行更严格的研究,以确定其疗效和安全性。需要进行标准化试验,以提供有关更年期治疗的益处和局限性的更准确信息,为寻求激素疗法替代品的妇女提供信息。黑升麻有可能降低接受他莫昔芬治疗的乳腺癌患者血管运动症状的频率和强度。除了能有效缓解盗汗和潮热外,黑升麻的血管舒张特性也对更年期症状产生了积极影响。由于存在差异、剂量和评估技术的不同,必须开展进一步的综合研究,以确定最佳剂量、长期安全性和总体疗效。只有通过标准化试验,妇女才能对黑升麻作为更年期激素疗法的可行替代品做出明智的决定。
{"title":"Exploring the Efficacy and Safety of Black Cohosh (<i>Cimicifuga racemosa</i>) in Menopausal Symptom Management.","authors":"Kritiksha Hedaoo, Ankit K Badge, Yugeshwari R Tiwade, Nandkishor J Bankar, Vaishnavi H Mishra","doi":"10.4103/jmh.jmh_242_23","DOIUrl":"10.4103/jmh.jmh_242_23","url":null,"abstract":"<p><p>Black cohosh (<i>Cimicifuga racemosa</i>) is a perennial plant used to treat menopause. This plant is known to have a serotonergic rather than estrogenic impact. It has been recommended to treat vasomotor symptoms associated with breast cancer patients. It also relieves symptoms such as night sweats and hot flashes, commonly called vasorelaxation. The variability in the study's results, doses, and assessment methods requires more rigorous research to establish its efficacy and safety. Standardized trials are needed to provide more precise information on the benefits and limitations of menopause treatment, informing women seeking alternatives to hormone therapy. Black cohosh has shown the potential to reduce the frequency and intensity of vasomotor symptoms in breast cancer patients undergoing tamoxifen treatment. In addition to its effectiveness in alleviating night sweats and hot flashes, the vasorelaxation properties contribute to its overall positive impact on menopausal symptoms. Due to discrepancies, varying dosages, and assessment techniques, further comprehensive studies are essential to determine the optimal dosage, long-term safety, and overall efficacy. Only through standardized trials can women make informed decisions about black cohosh as a viable alternative to hormone therapy during menopause.</p>","PeriodicalId":37717,"journal":{"name":"Journal of Mid-life Health","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11100637/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141066692","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An Innocuous-Looking Abdominal Wall Swelling in an Endometrial Cancer Survivor. 一名子宫内膜癌幸存者的腹壁肿胀看似无害。
IF 1.1 Q3 Social Sciences Pub Date : 2024-01-01 Epub Date: 2024-04-04 DOI: 10.4103/jmh.jmh_118_23
Deepti Choudhary, Pankhuri Jain, Rahul Kumar, Pankaj Kumar Garg

This case report describes a rare example of a solitary abdominal wall metastasis in a middle-aged endometrial cancer (EC) survivor 3 years following disease-free status. Following induction chemotherapy, she had a margin-negative surgical excision of the abdominal tumor. Surprisingly, the patient has been disease-free for more than 3 years after the operation. This emphasizes the necessity of addressing single metastasis amenable to surgical resection, as well as the need for diligent monitoring to discover recurrences sooner. Understanding rare locations of recurrence, such as the abdominal wall, is critical for optimum EC therapy and care. The data given in this article adds to the existing body of information on atypical presentations and recurrent EC therapy. Additional research is required to develop evidence-based guidance.

本病例报告描述了一名中年子宫内膜癌(EC)幸存者在无病状态 3 年后发生单发腹壁转移的罕见病例。诱导化疗后,她接受了边缘阴性的腹部肿瘤手术切除。令人惊讶的是,患者在术后 3 年多一直无病。这强调了处理适合手术切除的单发转移瘤的必要性,以及勤加监测以尽早发现复发的必要性。了解罕见的复发部位(如腹壁)对于优化 EC 治疗和护理至关重要。本文提供的数据为现有的非典型表现和EC复发治疗资料库增添了新的内容。要制定循证指导,还需要进行更多的研究。
{"title":"An Innocuous-Looking Abdominal Wall Swelling in an Endometrial Cancer Survivor.","authors":"Deepti Choudhary, Pankhuri Jain, Rahul Kumar, Pankaj Kumar Garg","doi":"10.4103/jmh.jmh_118_23","DOIUrl":"10.4103/jmh.jmh_118_23","url":null,"abstract":"<p><p>This case report describes a rare example of a solitary abdominal wall metastasis in a middle-aged endometrial cancer (EC) survivor 3 years following disease-free status. Following induction chemotherapy, she had a margin-negative surgical excision of the abdominal tumor. Surprisingly, the patient has been disease-free for more than 3 years after the operation. This emphasizes the necessity of addressing single metastasis amenable to surgical resection, as well as the need for diligent monitoring to discover recurrences sooner. Understanding rare locations of recurrence, such as the abdominal wall, is critical for optimum EC therapy and care. The data given in this article adds to the existing body of information on atypical presentations and recurrent EC therapy. Additional research is required to develop evidence-based guidance.</p>","PeriodicalId":37717,"journal":{"name":"Journal of Mid-life Health","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11100639/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141066160","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Mid-life Health
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1